# Clinical Investigation for Everolimus Drug Eluting Stent

> **NCT06769217** · PHASE4 · COMPLETED · sponsor: **Frisch Medical Device Private Limited** · enrollment: 888 (actual)

## Conditions studied

- Coronary Arterial Disease (CAD)

## Interventions

- **DEVICE:** Drug Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT06769217
- **Lead sponsor:** Frisch Medical Device Private Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-11-08
- **Final completion:** 2025-01-30
- **Target enrollment:** 888 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06769217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06769217, "Clinical Investigation for Everolimus Drug Eluting Stent". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06769217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*